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Abstract
Purpose: To review the literature comparing graft failure rate between patellar and hamstring tendon autografts placed 
anatomically and to determine if there are differences in return to preinjury activity levels between autografts. Study 
Design: Systematic review with meta-analysis and meta-regression. Methods: The PubMed, MEDLINE, SPORTDiscus, and 
CINAHL databases were used to identify studies published from January 1, 2000, through March 7, 2014. To compare 
postoperative outcomes between patellar tendon and hamstring tendon autografts, summary event rates for graft failure 
and return to preinjury activity level were calculated. A meta-analysis was performed to cal- culate a summary odds ratio 
(OR) for graft failure between autografts using the studies that directly compared the 2 autografts. Meta-regression analyses 
were performed to assess the influence of postoperative follow-up time on graft failure rate. Results: A total of 28 studies 
reported graft failures for patellar tendon (6 studies) and hamstring tendon (26 studies) autografts used with anatomic 
ACL reconstruction; 4 of the 28 were comparison studies. Graft failure rate was not significantly different between patellar 
tendon (7.0% [95% CI, 4.6%-10.5%]) and hamstring tendon autografts (3.9% [95% CI, 2.7%-5.6%]). The odds of graft 
failure were slightly higher for hamstring tendon autografts (OR, 1.21 [95% CI, 0.63-2.33]), but this difference was not 
significant (P = .57). The rate of patients returning to preinjury activity levels was not significantly different between patel- 
lar (n = 1 study; 58.1% [95% CI, 40.4%-73.9%]) and hamstring tendon autografts (n = 5 studies; 75.6% [95% CI, 
43.7%-92.5%]). Overall graft failure rate was positively associated with postoperative follow-up time, but this effect was 
only significant with ham- string tendon autografts (P \ .05). Conclusion: Differences in graft failure rate between patellar 
tendon and hamstring tendon autografts were not significant. Although follow-up time was only found to have a 
significant influence on hamstring tendon graft failure rates, this was likely due to the smaller sample of studies assessing 
patellar tendon graft failures. Differences in return to preinjury activity levels could not be determined due to the lack of 
studies assessing that outcome. Both patellar and hamstring tendon autografts demonstrate a low risk of failure and 
moderately high return to activity level after anatomic ACL reconstruction.
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Background: Recent data from the Danish anterior cruciate ligament (ACL) registry demonstrated increased reoperation rates for
hamstring tendon autografts when an anatomic ACL reconstruction is performed. This is consistent with reports of greater time
needed for hamstring tendon autografts to mature compared with other autografts.
Purpose: To review the literature comparing graft failure rate between patellar and hamstring tendon autografts placed anatom-
ically and to determine if there are differences in return to preinjury activity levels between autografts.
Study Design: Systematic review with meta-analysis and meta-regression.
Methods: The PubMed, MEDLINE, SPORTDiscus, and CINAHL databases were used to identify studies published from January
1, 2000, through March 7, 2014. To compare postoperative outcomes between patellar tendon and hamstring tendon autografts,
summary event rates for graft failure and return to preinjury activity level were calculated. A meta-analysis was performed to cal-
culate a summary odds ratio (OR) for graft failure between autografts using the studies that directly compared the 2 autografts.
Meta-regression analyses were performed to assess the influence of postoperative follow-up time on graft failure rate.
Results: A total of 28 studies reported graft failures for patellar tendon (6 studies) and hamstring tendon (26 studies) autografts
used with anatomic ACL reconstruction; 4 of the 28 were comparison studies. Graft failure rate was not significantly different
between patellar tendon (7.0% [95% CI, 4.6%-10.5%]) and hamstring tendon autografts (3.9% [95% CI, 2.7%-5.6%]). The
odds of graft failure were slightly higher for hamstring tendon autografts (OR, 1.21 [95% CI, 0.63-2.33]), but this difference
was not significant (P = .57). The rate of patients returning to preinjury activity levels was not significantly different between patel-
lar (n = 1 study; 58.1% [95% CI, 40.4%-73.9%]) and hamstring tendon autografts (n = 5 studies; 75.6% [95% CI, 43.7%-92.5%]).
Overall graft failure rate was positively associated with postoperative follow-up time, but this effect was only significant with ham-
string tendon autografts (P \ .05).
Conclusion: Differences in graft failure rate between patellar tendon and hamstring tendon autografts were not significant.
Although follow-up time was only found to have a significant influence on hamstring tendon graft failure rates, this was likely
due to the smaller sample of studies assessing patellar tendon graft failures. Differences in return to preinjury activity levels could
not be determined due to the lack of studies assessing that outcome. Both patellar and hamstring tendon autografts demonstrate
a low risk of failure and moderately high return to activity level after anatomic ACL reconstruction.
Keywords: anteromedial portal; autograft; systematic review; meta-analysis; meta-regression
Anterior cruciate ligament (ACL) injuries account for more
than 50% of all knee injuries,6 and they often become
a functional limitation during activities of daily living if
left untreated. Before the 21st century, transtibial ACL
reconstruction (ACLR) was the primary surgical treatment
for restoring joint stability, returning patients to their pre-
vious levels of activity, and reducing the risk of subsequent
joint injuries. Graft placement for transtibial ACLR is per-
formed by drilling the femoral tunnel through the tibial
tunnel, making the position of the femoral tunnel largely
dependent on the position of the tibial tunnel. However,
this technique commonly places the graft in a more vertical
position relative to the native ACL,43,46 which has been
shown to cause residual joint instability and inferior func-
tional outcomes.4,5,24 Since the early 2000s, surgical techni-
ques for ACLR have evolved to restore the anatomy of the
native ACL in attempts to improve postoperative outcomes.
‘‘Anatomic’’ ACLR is defined as a functional restoration
of the ACL to its native dimensions, orientation, and inser-
tion.60 The prime distinction of anatomic ACLR involves
placing the graft in the same position as the native ACL
by drilling the tunnels through the tibial and femoral ACL
footprints. To match the footprints of the native ACL, the
tibial and femoral tunnels must be drilled independent of
one another using an anteromedial drilling technique. In
this technique, the position of the tibial tunnel is identical
to transtibial ACLR, but instead of drilling transtibially to
create the femoral tunnel, a second portal is made antero-
medially (medial to the patellar tendon) to more accurately
target the femoral footprint of the ACL.42 This technique
allows the graft to better reflect the anatomic position of
the ACL and aims to restore its native function.
Over the past decade, anatomic ACLR has demonstrated
superior outcomes compared with transtibial ACLR with
regard to joint stability, return to activity, and the risk for
subsequent ipsilateral knee surgery.4,5,12,16,24,65 However,
recent data from the Danish ACL registry demonstrate an
increased revision rate with anatomic ACLR techniques,
but when stratifying their data by autograft type, anatomi-
cally placed hamstring tendon (HT) autografts demon-
strated 2 times the risk of revision (relative risk, 2.2)
compared with transtibially placed HT autografts, while
there were no risk differences between reconstruction tech-
niques for patellar tendon (PT) autografts.50 European
countries primarily use HT autografts when performing
ACLRs due to the negative outcomes often associated with
PT autografts (ie, donor-site morbidity, loss of knee-extensor
mechanism, and increased risk of developing patellofemoral
disorders).9,25,30 Conversely, HT autografts are known to
lead to increased joint laxity, hamstring weakness, and
slower graft-tunnel healing,10,17,38 which may explain why
a higher risk of revision was observed for HT autografts.
Numerous systematic reviews and meta-analyses have
been published within the past 15 years comparing postop-
erative outcomes between PT and HT autografts, but there
is mixed evidence with regard to which autograft has the
higher risk of failing. However, no publications have com-
pared graft failure rate between these 2 autografts when
placed via an anatomic ACLR technique.
The primary purpose of this study was to systematically
review, synthesize, and critically appraise the literature
comparing graft failure rate between PT and HT autografts
when an anatomic ACLR technique is used. Our secondary
purpose was to compare the rate of patients who return to
their preinjury levels of activity based on the type of auto-
graft they received for anatomic ACLR. Return to preinjury
activity level (RTAL) is an important postoperative outcome
because it encompasses both function and quality of life. By
using both graft failure rate and RTAL rate as our outcome
measures, it allows us to better delineate the success of
anatomic ACLR when comparing the autografts. We
hypothesized that HT autografts would demonstrate a sig-
nificantly greater failure rate than PT autografts but that
RTAL rate would not differ between the two.
METHODS
Review Protocol
The PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) guidelines (www.prisma-
statement.org) were used to conduct our systematic review
and meta-analysis. The PRISMA checklist is available in
the Appendix (available in the online version of this article
at http://ajsm.sagepub.com/supplemental).
Information Sources
The databases used for the electronic search included
PubMed, MEDLINE, SPORTDiscus, and CINAHL. The
latter 3 databases were searched using EBSCOhost. Our
search was restricted to English-language publications,
human subject studies, and academic journal articles
from January 1, 2000, through March 7, 2014.
Search
The search strategy is presented in Table 1. Hand-
searched articles were identified through the reference
lists of the articles included in the qualitative synthesis.
TABLE 1
Stepwise PubMed/EBSCOhost Search Strategya
Step Strategy PubMed EBSCOhost
1 Search ‘‘ACL OR anterior
cruciate ligament’’
7578 13,108
2 Search ‘‘reconstruct*’’ 85,384 95,662
3 Search ‘‘anatomic OR anteromedial
portal OR native’’
72,627 80,587
4 Search ‘‘cadaver OR allograft’’ 42,881 46,756
5 Search ‘‘#1 AND #2’’ 4042 6848
6 Search ‘‘#5 AND #3’’ 588 898
7 Search ‘‘#6 NOT #4’’ 358 580
aBolded numbers indicate the final number of articles that were
searched through after the search term strategy was performed in
each database.
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Eligibility Criteria
Only those studies providing level 3 evidence or higher
(based on the Oxford Levels of Evidence41) were assessed
in this review. For a study to be included in the qualitative
synthesis, both an anatomic (or anteromedial portal) tech-
nique and autograft (PT or HT) had to be used for the
ACLR. Follow-up assessments after surgery had to involve
either objective ACL graft failure (retear or primary revi-
sion) confirmed via magnetic resonance imaging and/or
first-look arthroscopy or subjective physical activity status
with a minimal postoperative follow-up period of 24 months.
We chose a cutoff of 24 months because most ACLR outcome
studies include a minimum 2-year postoperative follow-up
assessment. There were no restrictions on study design,
but the studies had to involve human subjects who were
diagnosed with a primary ACL tear (via magnetic resonance
imaging or arthroscopy) and subsequently underwent ana-
tomic ACLR. Studies were excluded if an anatomic ACLR
technique was not performed, an allograft was used to
reconstruct the ACL, follow-up assessments were conducted
less than a mean of 24 months after surgery, or if there were
no data reported on either graft failure or return to prein-
jury physical activity levels. Those patients who reportedly
developed a Cyclops lesion were removed from the analyses.
Study Selection
The study selection process used for this systematic review
consisted of 4 stages. After articles were identified through
the electronic search and duplicates were removed (stage 1),
their titles and abstracts were screened by one of the
authors (C.M.G.) to determine if they were applicable for
the purpose of the systematic review (stage 2). Once
screened, the same author assessed the remaining articles
for eligibility by reading through each of the methods and
results sections (stage 3). Those studies deemed eligible
were included in the qualitative synthesis along with the
hand-searched articles (stage 4) by consensus of 2 authors
(C.M.G. and C.A.J.). If the 2 authors disagreed on a decision
to include or exclude an article and they could not come to
a consensus, a third author (D.L.J.) was brought in to
make the final decision. If studies were discovered to have
shared data, only the most recent study was included.
An initial total of 938 hits were identified through PubMed
and EBSCOhost (MEDLINE, SPORTDiscus, and CINAHL).
After removing the duplicates between the databases, 433
articles remained. Of these 433 articles, 375 were excluded
after screening their titles and abstracts. The primary rea-
sons for excluding these articles were irrelevancy and if the
outcomes mentioned in the abstract did not entail graft integ-
rity or physical activity measures. The methods and results
sections of the remaining 58 articles were then read to deter-
mine if they were eligible for inclusion. Forty of the articles
were excluded because they did not use an anatomic ACLR
technique, reported neither graft failure numbers nor the
rate of patients who returned to preinjury activity levels, or
shared data with an included study. Lastly, 10 additional
articles were added to the qualitative synthesis after search-
ing through the reference lists of the remaining 18
electronically searched articles, resulting in a total of 28 stud-
ies being included in the systematic review. Figure 1 provides
a flow diagram of the search strategy used for study selection.
Data Extraction
Data extraction of the included studies was performed by
one author (C.M.G.), and a second author (C.A.J.) checked
the extracted data for accuracy. A spreadsheet was used
for each autograft type (PT and HT) to organize and store
data, including reference, study design, mean follow-up
period after ACLR, sample size, type of autograft harvest,
type of graft bundle used, type of graft fixation used (fem-
oral and tibial), number of graft failures, and number of
patients who returned to their preinjury activity levels.
Summary Measures
Summary event rates were analyzed using Comprehensive
Meta-Analysis software (Biostat). The event rates (in per-
centages) for graft failure and RTAL were the primary
measures of treatment effect based on autograft type
used for anatomic ACLR. Graft failures were classified as
retears or primary ACL revisions, and RTAL was derived
from either the International Knee Documentation Com-
mittee Subjective Knee Form (question 10) or the Tegner
activity scale. Summary event rates were calculated by
weighing event rates from each individual study according
to their sample size and variability. Summary event rates
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Figure 1. Search strategy used for study selection.
were calculated for all data extracted from the studies and
when dividing the data by autograft type (PT vs HT). By
examining the 95% CIs of the summary event rates for PT
and HT autografts, differences can be reported if there is
overlap between the CIs of the 2 autografts.
The secondary measures included mean sample size,
mean postoperative follow-up time, and mean Coleman
Methodology Score (CMS) scores. We were interested in
both the overall mean values from all studies included in
the review and the mean values when separating the data
by autograft type (PT vs HT). These secondary measures
were considered useful for understanding study characteris-
tics and interpreting the results. Differences in secondary
measures between PT and HT autografts were assessed
using independent sample t tests. These statistical tests
were performed using SPSS version 22 (SPSS Inc), with
the significance level established a priori at P  .05.
To calculate a summary odds ratio (with 95% CI)
between the 2 autografts, we also performed a meta-
analysis on the studies that prospectively compared graft
failure data with PT and HT autografts. A forest plot
was generated from the meta-analysis displaying the
weighted odds ratios (ORs) of the included studies and
a summary OR. Comprehensive Meta-Analysis software
was used to perform these analyses. Statistical significance
was defined as P  .05 (95% CI did not cross 1).
Synthesis of Results
Given the observed heterogeneity in study designs and sam-
ple sizes among the studies, random-effects DerSimonian
and Laird models were used for the meta-analyses. To sup-
port the use of the random-effects model, we also conducted
statistical tests of heterogeneity. The P value of the Cochran
Q statistic (test for heterogeneity) was used to test the null
hypothesis that event rates were the same in all studies (P
. .05). To quantify the effect of heterogeneity in the studies’
results, an I2 statistic was also calculated (I2 = 100% 3 (Q –
df)/Q). The I2 describes the percentage of total variation
across studies that are due to heterogeneity instead of
chance. Moderate to high values of I2 (~50% or higher) sug-
gest the use of a random-effects models for meta-analysis to
explain the effect of heterogeneity.21
Meta-regression Analyses
To assess the effect of follow-up duration on both the graft
failure rate and RTAL rates, respectively, we performed 2
separate meta-regression analyses. Mean postoperative
follow-up duration was labeled as the continuous modera-
tor and used as the covariate (predictor) in the regression
analysis predicting the log odds of the events of interest
(graft failure rate and RTAL rate). All anatomic ACLR
studies included in the systematic review that provided
graft failure and RTAL event rates were included in the
meta-regression. If follow-up duration was found to have
a significant influence (regression slope P  .05) on either
graft failure rate or RTAL rate, subgroup meta-regression
analyses were conducted for each autograft type (PT and
HT) to determine if mean follow-up duration had
a significant effect on either outcome depending on which
autograft was used for anatomic ACLR. To reduce the
potential effect of heterogeneity, random-effects (method
of moments) models were used for the meta-regression
analyses.
Publication Bias
To detect for signs of publication bias, we created a stan-
dard funnel plot by plotting the log odds of the event rate
against standard error. The event rate chosen to be used
for the funnel plot (graft failure or RTAL) was the event
reported in most included studies.
Quality Assessment
To assess study quality, we used the CMS for each of the
included studies. The CMS is a tool created to assess the
methodological quality of surgical outcome studies.11 It con-
sists of 18 questions that assess characteristics such as study
design and sample size, with a score ranging from 0 to 100
(100 representing a perfect score). The main object of the
tool is to identify the influence of chance, bias, and confound-
ing factors on the reported results. It was originally devel-
oped for the surgical management of patellar tendinopathy,
but over the years, it has been modified for various orthopae-
dic conditions such as Achilles tendinopathy,58 meniscec-
tomy,45 and articular cartilage repair.22,39 For the purposes
of this review, the CMS was used for ACLR.
RESULTS
Study Characteristics
The 28 studies provided data on a total of 2407 subjects who
had previously undergone anatomic ACLR. For each study,
patient characteristics were extracted and organized into
tables by autograft type to allow for comparison between
autograft types. Study characteristics for PT autografts
and HT autografts can be seen in Tables 2 and 3, respec-
tively. Most of the included studies (26 studies) consisted
of HT autografts (2032 subjects), while only 6 studies used
PT autografts (375 subjects).14,44,48,52,62,63 Four stud-
ies48,52,62,63 were comparative studies that examined both
PT and HT autografts. All studies were either randomized
clinical trials (evidence level 2) or prospective cohorts (evi-
dence level 3).41 Half (3/6) of the PT autograft studies
were randomized clinical trials (level 2 evidence), whereas
62% (16/26) of HT autograft studies were randomized clini-
cal trials. After data were extracted for the primary outcome
measures, all 28 studies reported graft failure data, with
only 5 of those studies2,3,20,26,52 (341 subjects) reporting
RTAL data. Of the 5 studies, only 1 provided RTAL data
on PT autografts (31 subjects),52 while the other 4 studies
concerned HT autografts (310 subjects).31-34
Outcome Measures
All summary event rates are reported in Table 4. The sum-
mary graft failure rate and RTAL rate from all anatomic
ACLR studies were 4.6% (95% CI, 3.4%-6.3%) and 71.7%
(95% CI, 45.4%-88.5%), respectively. When comparing
graft failure rate and RTAL rate between PT and HT auto-
grafts, no significant differences were observed (overlap-
ping 95% CIs). The summary ORs for graft failure
derived from the meta-analysis of the 4 comparative stud-
ies (see Figure 2) were not significant (1.21; 95% CI, 0.63-
2.33; P = .57). Only 1 comparative study provided RTAL
data for PT autografts.52 Therefore, it was not possible to
perform a meta-analysis to determine the odds of RTAL
between autografts.
The mean (6SD) sample size of the studies included in
this review was 75.2 6 60.3 patients. There were no signif-
icant differences in mean sample size between PT (62.5 6
50.4 patients) and HT (78.2 6 62.9 patients) autograft data
(t(30) = 20.57, P = .58). The mean follow-up time for all
TABLE 2
Characteristics of Studies Using Patellar Tendon Autografts
for Anatomic Anterior Cruciate Ligament Reconstructiona
Study (Year)
Study
Design
Mean Follow-up,
mo
Sample
Size, n
Harvest
Type Bundle FemFix TibFix GF, n RTAL, n
Felmet (2010)14 PC 123.6 154 BPTB SB BBPF BBPF 6
Otsuka et al (2003)44 RCT 24 20 BPTB SB IS IS 0
Pinczewski et al (2007)48 PC 120 82 BPTB SB IS IS 7
Sajovic et al (2011)52 RCT 132 31 BPTB SB IS BAIS 4 18
Wagner et al (2005)62 PC 24 59 BPTB SB BAIS BAIS 3
Wipfler et al (2011)63 RCT 105.6 29 BPTB SB BBPF Sutures 3
aBAIS, bioabsorbable interference screws; BBPF, bone block press-fit; BPTB, bone–patellar tendon–bone; FemFix, femoral fixation; GF,
graft failure; IS, metal interference screws; PC, prospective cohort; RCT, randomized clinical trial; RTAL, returned to preinjury activity
level; SB, single bundle; TibFix, tibial fixation.
TABLE 3
Characteristics of Studies Using Hamstring Tendon Autografts
for Anatomic Anterior Cruciate Ligament Reconstructiona
Study (Year)
Study
Design
Mean Follow-
up, mo
Sample
Size, n
Harvest
Type Bundle FemFix TibFix GF, n RTAL, n
Aglietti et al (2007)1 PC 24 25 STG DB IS IS 1
Aglietti et al (2010)2 RCT 24 70 STG SB/DB IS Sutures 4 43
Ahldén et al (2013)3 RCT 24 98 STG SB/DB IS BAIS 0 22
Ferretti et al (2008)15 RCT 25 31 STG SB SWB IS 0
Gobbi et al (2012)20 RCT 36 60 ST SB/DB EB BAIS 0 60
Hussein et al (2012)23 PC 30 94 STG SB/DB EB BAIS 2
Hussein et al (2012)24 RCT 51 221 STG SB/DB EB BAIS 3
Ibrahim et al (2009)26 RCT 29 50 STG DB EB BAIS 0 47
Jagodzinski et al (2010)27 RCT 24 20 STG SB CP IS/BBPF 1
Jarvela et al (2008)29 RCT 24 70 STG SB/DB BAIS/IS BAIS/IS 7
Kondo et al (2008)31 PC 24 171 STG DB EB Staples 1
Kondo et al (2012)32 PC 24 47 STG DB EB Staples 1
Laxdal et al (2006)33 RCT 24 71 STG SB BAIS/IS BAIS/IS 3
Nunez et al (2012)40 RCT 24 52 STG SB/DB EB BAIS 0
Pinczewski et al (2007)48 PC 120 86 STG SB IS IS 12
Plaweski et al (2009)49 PC 51 105 STG SB EB BAIS 4
Sajovic et al (2011)52 RCT 132 32 STG SB IS BAIS 2 22
Stener et al (2010)54 RCT 96 64 STG SB BAIS/IS BAIS/IS 3
Sun et al (2011)55 RCT 41.5 36 STG SB EB BAIS 0
Sun et al (2011)56 RCT 91.2 91 STG SB EB BAIS 0
Suomalainen et al (2013)57 PC 24 46 STG SB/DB IS BAIS 4
Tohyama et al (2011)59 PC 24 122 STG DB EB Staples 0
Wagner et al (2005)62 PC 24 284 STG SB BAIS BAIS 16
Wipfler et al (2011)63 RCT 105.6 25 STG DB Knotted Sutures 3
Yasuda et al (2006)65 PC 24 24 STG DB EB Staples 0
Zaffagnini et al (2008)66 RCT 36 37 STG DB Staples Staples 0
aBAIS, bioabsorbable interference screws; BBPF, bone block press-fit; CP, cross-pins; DB, double bundle; EB, endobutton; FemFix, fem-
oral fixation; GF, graft failure; IS, metal interference screws; PC, prospective cohort; RCT, randomized clinical trial; RTAL, returned to pre-
injury activity level; SB, single bundle; ST, semitendinosus; STG, semitendinosus and gracilis; SWB, swing bride; TibFix, tibial fixation.
studies was 52.7 6 40.4 months. When examining mean
postoperative follow-up time between autograft types, a sig-
nificant difference between PT (88.2 6 50.5 months) and
HT (44.5 6 33.7 months) autograft data was observed
(t(30) = 2.61, P = .01).
Due to graft failure being reported in all included stud-
ies, statistical tests for heterogeneity were used to deter-
mine if graft failure rates were the same in all studies.
The results from the Cochran Q test rejected the null
hypothesis, revealing that there was heterogeneity across
the studies (Q(31) = 56.1, P = .004). Furthermore, the I2 sta-
tistic revealed that nearly half of the total variation
observed across studies was due to heterogeneity instead
of chance (I2 = 44.7%). These findings justified the choice
of using a random-effects model for conducting the analyses.
Meta-regression Results
The results of the meta-regression analyses can be
observed in Table 5. Mean postoperative follow-up time
was a significant predictor of graft failure rate after ana-
tomic ACLR (Z = 2.70, P = .007) as revealed by the meta-
regression on all 28 studies that reported graft failure
data. The subgroup meta-regression analyses on autograft
type revealed that follow-up time was a significant predic-
tor for graft failure rate when HT autografts were used for
anatomic ACLR (Z = 1.99, P = .047), with graft failure rates
increasing as the length of follow-up time increased. This
same effect did not achieve statistical significance for PT
autografts (Z = 0.84, P = .401). However, the overlapping
95% CIs observed between the PT (95% CI, –0.007 to
0.018) and HT (95% CI, 0.0 to 0.02) regression slopes dem-
onstrated no significant differences. Based on the 5 studies
that reported RTAL data, follow-up time was not found to
significantly predict RTAL rate after anatomic ACLR (Z =
20.33, P = .74). Due to there being only 1 study that
reported RTAL data for PT autografts, there were insuffi-
cient data to perform subgroup meta-regression analyses
on RTAL rate by autograft type.
Quality Assessment
The overall mean (6SD) CMS score for all 28 studies was
81.6 6 6.8 out of a possible 100 points, indicating that the
studies included in the systematic review were of moderate
to high methodological quality. There were no significant
differences in mean CMS scores between PT (80.2 6 7.7)
and HT (82.1 6 6.7) autograft data (t(30) = 20.63, P = .53).
Publication Bias
Since all studies included in this review reported graft fail-
ure data, funnel plots were created by plotting the log odds
of graft failure rate against the standard error. When
examining the standard funnel plot (Figure 3), some asym-
metry can be observed, suggesting a publication bias for
graft failure data.
DISCUSSION
The purpose of this systematic review was to synthesize
and critically appraise the literature comparing event
rates for graft failure and RTAL between PT and HT auto-
grafts when using an anatomic ACLR technique. Graft fail-
ure rate was not significantly different between PT
autografts (7.0%) and HT autografts (3.9%), with both
demonstrating a low occurrence of graft failure. However,
it must be considered that the mean postoperative follow-
up period from the PT autograft data (88.2 months) was
significantly longer than that for the HT autograft data
TABLE 4
Summary Event Rates for Graft Failures
and Return to Preinjury Activity Levelsa
Graft
Graft Failure
Rate (95% CI)
RTAL Rate
(95% CI)
All 4.6 (3.4-6.3) 71.7 (45.4-88.5)
Patellar tendon 7.0 (4.6-10.5) 58.1 (40.4-73.9)
Hamstring tendon 3.9 (2.7-5.6) 75.6 (43.7-92.5)
aEvent rates are reported in percentages. RTAL, return to pre-
injury activity level.
Study Statistics for each study ORs and 95% CIs
OR 95% CI Z P 
1.737 0.648-4.657 1.098 .272
0.450 0.076-2.656 –0.882 .378
1.114 0.314-3.954 0.168 .867
1.182 0.216-6.457 0.193 .847
1.209 0.627-2.333 0.567 .571
0.1 0.2 0.5 1 2 5 10
Pinczewski et al48
Sajovic et al 52
Wagner et al 62
Wipfler et al 63
Favors HT       Favors PT
Figure 2. Forest plot of the 4 studies comparing graft failure
outcomes between patellar tendon (PT) and hamstring ten-
don (HT) autografts. Point estimates of the weighted odds
ratios for each study are represented by squares, and the
95% CIs are represented by horizontal bars. The summary
odds ratio is represented by a gray diamond.
TABLE 5
Single-Variable Meta-regression Random-Effects Model
Using Mean Postoperative Follow-up Time
as a Predictor Variablea
Graft Failure Rate
Autograft Type
(No. of Studies)
Slope (SE) 95% CI P Value
All autografts
(28 studies)
0.009 (0.003) 0.003 to 0.016 .007b
Patellar tendon
(6 studies)
0.005 (0.007) –0.007 to 0.018 .401
Hamstring tendon
(26 studies)
0.010 (0.005) 0.000 to 0.020 .047b
aEvent rates are in log odds units. SE, standard error.
bStatistically significant predictive effect (P  .05).
(44.5 months). This discrepancy suggests that if the mean
postoperative follow-up time between the 2 autografts
were equal, an increased number of HT graft failures
would have accrued, and the failure rate observed for HT
autografts would have likely been more similar to that of
the PT autografts.
The results from the meta-regression analysis of all
available data revealed that mean postoperative follow-up
time positively influenced graft failure rate. Interestingly,
the subgroup meta-regression analyses demonstrated that
failure rate for HT autografts was significantly influenced
by follow-up time, but this same effect was not significant
for PT autografts. Although the slope of the regression
line for HT (0.01) and PT (0.005) autografts appears to be
different, their respective 95% CIs overlap. Furthermore,
when plotting follow-up time by graft failure rate, the dura-
bility of both autografts appears to be equally influenced by
time (Figure 4). The failure to achieve statistical signifi-
cance in the PT autograft analysis was likely due to the
small sample of studies providing PT graft failure data
(PT = 6 data samples, HT = 26 data samples). Therefore,
if more PT autograft data were available, follow-up time
may have exhibited the same predictive effect on PT graft
failures. However, to support the above hypotheses, more
long-term follow-up anatomic ACLR studies on HT auto-
grafts and studies reporting graft failure data from PT auto-
grafts are needed.
While the summary OR (1.21) derived from the meta-
analysis suggested a slightly higher odds of failure with
HT autografts, this finding was not significant (P = .57).
Furthermore, the 95% CI crossed 1, which verifies that lit-
tle confidence can be given to differences in graft failure
rate between the 2 autografts. Thus, neither autograft
choice placed patients at greater odds for graft failure after
anatomic ACLR. These findings further support our initial
finding of no significant differences in graft failure rate
between PT and HT autografts. Unlike the summary event
rates and OR calculated from the 28 studies included in
this review, the meta-analysis consisted of only the 4 stud-
ies47,48,52,63 that prospectively compared postoperative out-
comes between PT and HT autografts. When combining
the data on graft failures of these 4 studies, the graft fail-
ure rates for PT and HT autografts are both 8.8%. These
graft failure rates are in agreement with those reported
in our results, because they demonstrate no significant dif-
ferences. Given that these 4 studies directly compared
graft failures between PT and HT autografts, they provide
high-level evidence to reject differences in graft failure rate
between PT and HT autografts.
Our findings refute those of a recent study from the
Danish ACL registry that compared the risk of ACL revi-
sion surgery between anatomic and nonanatomic ACLR
techniques.50 They found anatomic ACLR to be associated
with an increased risk of revision compared with nonana-
tomic techniques, but when stratifying their analyses by
autograft type, this difference was only true for patients
who received HT autografts (relative risk, 2.2) and not
for those who received PT autografts. Therefore, it was
concluded that patients who receive HT autografts are at
a greater risk of failure when an anatomic ACLR technique
is performed. A major limitation of their study is that they
only reported data on ACL revisions and did not capture
data on patients who tore their ACL graft but had not
undergone a revision. This prevented them from reporting
true event rates because they did not account for those
patients who tore their graft and have yet to undergo
a revision surgery. An advantage of this current review
is that we defined graft failure as either an ACL revision
or graft tear (excluding Cyclops lesions), thus allowing us
to more accurately report the event rate for graft failure.
Within the past 30 years, there have been a number of
systematic reviews and meta-analyses comparing postop-
erative outcomes between PT and HT autografts, not spe-
cifically comparing the graft placement technique
(anatomic or nonanatomic) used for ACLR.8,17,19,34-36,51,53
Even with this breadth of literature, the evidence for dif-
ferences in graft failure rate remains inconclusive. Some
of these studies17,19,51 reported lower graft failure rates
for PT autografts compared with HT autografts, while
Figure 3. Funnel plot with 95% CIs about a random-effects
estimate. Log Odds GFR, log odds of graft failure rate.
Figure 4. Scatterplot of summary graft failure rates (%) and
mean postoperative follow-up time (months), comparing
autograft types. Studies reporting graft failure data for patel-
lar tendon autografts are represented by diamonds, and
those reporting graft failure data for hamstring tendon auto-
grafts are represented by empty circles. Linear trendlines
for both patellar tendon autografts are represented by a solid
line, and hamstring tendon autografts are represented by
a dashed line.
the other studies have reported no significant differences
between the 2 autografts with regard to graft failure
rate.34-36,53 A possible explanation as to why a higher graft
failure rate was observed in some of the studies could be
due to the slower bone-tunnel healing rate of HT auto-
grafts compared with PT autografts. It has been estab-
lished that more time (1 year) is needed for HT
autografts to fully mature compared with nonsynovialized
grafts such as PT autografts.28,37 Therefore, a more
delayed return to dynamic activities may be warranted
for patients with HT autografts.
A higher graft failure rate for anatomic ACLR compared
with nonanatomic techniques has previously been reported
in a systematic review by Alentorn-Geli et al.4 Their
results indicated that 5.7% of patients in the anatomic
ACLR group sustained graft failures, while only 2.3% of
patients in the nonanatomic ACLR group failed. Their
graft failure rate for anatomic ACLR was similar to what
was reported in this review (4.6%). However, anatomic
ACLR has repeatedly been shown to be superior in restor-
ing anterior-posterior and rotational stability in the knee
compared with nonanatomic techniques,4,5,16,24 thus allow-
ing patients to return to dynamic activities sooner.4,5 It has
been demonstrated that anatomically placed grafts carry
greater loads compared with nonanatomically placed
grafts.64 It is hypothesized that patients who receive ana-
tomic ACLR are more likely to return to dynamic activities
too soon, exposing their graft to greater loads and therefore
putting them at a greater risk for failure before their graft
has fully matured.18,50 These patterns may help to explain
why early ACL graft failure and revision rates have been
reported to be higher for anatomic ACLR compared with
nonanatomic techniques. However, this causal relation-
ship cannot be determined until more studies report return
to activity data after anatomic ACLR.
The true advantage of anatomic ACLR techniques may
not lie in the first 2 postoperative years but in the long-
term condition of the knee. While transtibial ACLR has rel-
atively low early graft failure rates, the rate of long-term
failure due to degenerative changes and osteoarthritis is
tremendous. More than half of transtibial ACLR patients
demonstrated radiographic evidence of grade 2 or higher
joint degenerative changes at 14 years.7,61 As such, the
potential advantages of improved anterior-posterior and
rotational stability associated with anatomic techniques
may not be realized until longer follow-up is available.
Return to Preinjury Activity Levels
The event rate of patients who return to their preinjury
activity levels after ACLR is a postoperative measure
that is underreported in outcome studies but largely deter-
mines the degree of recovery in patients. The RTAL rate
reported in this review appears to be different between
PT and HT autografts (58.1% vs 75.6%, respectively), but
due to only a single PT study reporting RTAL and the
wide CIs observed among HT studies, a true statistical dif-
ference between the 2 autografts could not be concluded.
The RTAL rate reported for PT autografts in this review
is derived from 1 study by Sajovic et al52 that examined
11-year follow-up outcomes. Although this study provided
a high level of evidence, being a randomized clinical trial,
it should still be interpreted with caution since the data
were extracted from one sample. More prospective, com-
parative studies that report RTAL data in patients who
have undergone anatomic ACLR are needed to perform
meta-analyses and truly assess differences in RTAL rate
between PT and HT autografts.
Our results also revealed that 71.7% of the patients for
whom RTAL data were provided returned to their prein-
jury activity levels after anatomic ACLR. This value was
in agreement with what we expected for anatomic ACLR.
In a retrospective comparative study, Franceschi et al16
observed that at a minimum postoperative follow-up of 5
years, more than 80% of the patients who underwent ana-
tomic ACLR (with HT autografts) returned to their prein-
jury activity levels, whereas only 65% of patients
returned to their preinjury activity levels after nonana-
tomic ACLR. Furthermore, studies4,5,24 comparing these
2 ACLR techniques have demonstrated that patients who
have undergone an anatomic technique return to activities
of daily living sooner and have better subjective knee out-
come scores than those who have undergone nonanatomic
techniques. Since anatomic ACLR has been shown to
restore functional knee stability more effectively than non-
anatomic techniques,4,5,24 it is logical to assume that
patients’ knees will feel more like ‘‘normal,’’ making them
more likely to return to the same activities they had partic-
ipated in before sustaining an ACL injury.
Quality of Literature
The overall CMS score for all 28 studies included in this
systematic review was 81.6 out of 100. This score was
encouraging given the number of case series and retrospec-
tive studies that were included. Despite the moderately
high CMS score of the studies included in this review,
the strength of recommendation of this review can only
be considered as evidence level 2.13 When examining the
CMS scores by autograft type, differences in methodologi-
cal quality can be observed. The studies assessing both
PT and HT autografts scored moderately high on the
CMS (80.2/100 and 82.1/100, respectively). The most com-
mon reasons why studies lost points on the CMS were
because they did not report the reliability/validity of their
outcome measures, or the investigators were not indepen-
dent of the surgeon.
Limitations
Several limitations involved in this review should be con-
sidered when interpreting the results. Of 28 studies
included in this review, only 4 prospectively compared
postoperative outcomes between autograft types used for
anatomic ACLR. For the rest of the studies, we extracted
cohort data on patients who underwent anatomic ACLR
and whose data were specified by autograft type. The liter-
ature on postoperative outcomes after anatomic ACLR has
been published only within the past decade; thus, it was
foreseen that there would be a limited number of high-level
evidence studies. We did not elect to only review the 4
aforementioned studies because our aim was to provide
a comprehensive review on all available evidence to
answer our clinical question.
Another limitation of this review was that the data sam-
ples and mean postoperative follow-up periods were not
equal between autograft types. The number of data samples
was substantially higher for HT autografts (26 samples)
compared with PT autografts (6 samples). Although the
PT autograft studies provided nearly 400 patients, the
more than 2000 patients provided by the HT autograft stud-
ies gives them an advantage related to representation of the
data. Conversely, the PT autograft studies demonstrated
a longer mean postoperative period of more than 7 years
(almost 4 years longer than the HT studies). Although an
inclusion criterion was that postoperative outcome data
must be reported at least 24 months after anatomic ACLR
to be included in this review, we did not put a limit on the
length of follow-up. If the follow-up periods for the HT auto-
graft studies were the same length as the PT autograft stud-
ies, we may have observed a greater number of subsequent
graft failures in that population. This hypothesis is further
supported by the meta-regression data demonstrating a sig-
nificant relationship between follow-up time and graft fail-
ure rate among HT autograft studies.
Lastly, we were unable to determine whether there were
differences in the time span from anatomic ACLR to graft
failure between PT and HT autografts. These data would
have provided insight into the longevity and the temporal
failure trends of both autografts and whether these charac-
teristics were different between the two. Assessing the time
to failure of anatomically placed autografts was a prelimi-
nary goal of this review. However, during the data extrac-
tion process, it became evident that only a minority of the
studies included in this review provided time-to-failure
information on those patients who sustained graft failure
after anatomic ACLR. Although we found postoperative fol-
low-up time to have a positive association with graft failure
rate, there were not enough data available for us to deter-
mine when most of these graft failures took place after sur-
gery or whether there were temporal differences between
autografts. Time to failure is a factor that warrants atten-
tion and should be assessed to gain more knowledge about
the durability of surgical techniques used with ACLR.
CONCLUSION
The results from this review demonstrated a low rate of
graft failure for anatomic ACLR, with no significant differ-
ences in failure rates between PT and HT autografts. Fur-
thermore, there was no difference in the odds of graft
failure between PT and HT autografts when using an ana-
tomic ACLR technique. Graft failure rates for anatomic
ACLR were influenced by postoperative follow-up time,
but this effect was significant only for HT autografts.
This same temporal effect was not demonstrated with PT
graft failure rates, likely due to the smaller sample of stud-
ies compared with HT autografts. Just over 70% of the
patients who underwent anatomic ACLR were observed
to return to their preinjury levels of activity, with no differ-
ences between autografts. Due to the lack of randomized
clinical trials comparing postoperative outcomes between
autografts used for anatomic ACLR, we are unable to
definitively conclude that one graft is superior with regard
to achieving a successful recovery. Since graft integrity
and returning patients to their preinjury activity levels
largely define surgical success, it is strongly encouraged
that further research be conducted assessing these postop-
erative outcomes in patients who have undergone ana-
tomic ACLR. In addition, future investigations comparing
postoperative outcomes between surgical techniques are
encouraged to account for differences in postoperative fol-
low-up time when conducting their analyses.
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